Given the multifaceted nature of ADCs, developers should have an integrated analytical toolkit. Three complementary approaches dominate the current landscape: Ligand Binding Assays (LBA): Ideal for ...

Illumina unveiled the Billion Cell Atlas, a large‑scale genetic perturbation dataset built with pharma partners to advance AI‑powered drug discovery, target validation, and disease biology.

Our results provide mechanistic evidence that immune responses to EBV can directly damage the brain in MS,” said Olivia Thomas, PhD, assistant professor at the Department of Clinical Neuroscience at ...

Silicon Valley microprocessing giant NVIDIA and pharma powerhouse Eli Lilly announced a five-year, $1 billion partnership to create a “Co-Innovation AI Lab” designed to address key challenges in AI ...

Charles River Laboratories will pay $60 million for the remaining shares of PathoQuest and $510 million for acquiring K.F.

A novel lentiviral packaging system enables production from a single-plasmid transfection instead of the standard four-plasmid process.

Researchers say the living sensor display technology may have potential applications beyond human healthcare, in veterinary ...

The largest single cell perturbation dataset to-date will be generated and released open source in a new team effort.

Data indicate that the AutoCell platform could pave the way for CGTs for the first time as first-line therapies.

Trained on 9.7 trillion tokens of evolutionary data, EDEN designs therapeutics from large gene insertion to antimicrobial peptides.

Researchers suggest that, from a clinical perspective, the findings provide mechanistic insight into motivational deficits central to psychiatric disorders.

PanMAN data structures compress pangenomes massively, encode evolutionary histories, and enable scalable analysis of millions of genomes.